Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Abroad (travel likely)RecruitingPHASE2

Conditions

Chronic Myeloid Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Fadi Haddad, MD) · fhaddad@mdanderson.org · 346-234-4135
Contact: Principal Investigator (Fadi Haddad, MD)

Study leads

Fadi Haddad, MD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Olverembatinib (HQP1351) in Patients With CP-CML

Chronic Myeloid Leukemia · CML · CML, Chronic Phase

Abroad (travel likely)RecruitingPHASE3

Houston, United States

Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors

Acute Myeloid Leukemia · Accelerated Phase Chronic Myeloid Leukemia · Blast Phase Chronic Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1, PHASE2

Ghent, Belgium · Paris, France

Second STOP After Pioglitazone Priming in CML Patients

Chronic Myeloid Leukemia (CML)

Abroad (travel likely)RecruitingPHASE2

Le Chesnay, France · Le Kremlin-Bicêtre, France

Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

Acute Myeloid Leukemia, Relapsed, Adult · Acute Myeloid Leukemia Refractory · Chronic Myeloid Leukemia - Accelerated Phase

Abroad (travel likely)RecruitingPHASE2

Chicago, United States